Prevalence of Pain Higher in Children With Autism Spectrum Disorder
Children with autism spectrum disorder (ASD) have an elevated prevalence of pain compared with children without ASD.
Autism Spectrum Disorders
Fetal Exposure to Acetaminophen May Increase Risk for ADHD and Autism
Cord biomarkers of fetal exposure to acetaminophen are associated with an increased risk for childhood ADHD and autism spectrum disorder.
Effect of Fluoxetine on Repetitive Behaviors in Children With Autism Unclear
Treatment with fluoxetine appears to result in significantly lower scores for obsessive compulsive behaviors at 16 weeks among children and adolescents with ASD, but interpretation of the data is limited.
FDA and FTC Issue Joint Warning Letter to Company Selling Unproven CBD Products
Company claimed their CBD products can be used to treat a variety of conditions and diseases including teething pain and earaches in infants, skin problems, autism, ADHD, Parkinson disease, and Alzheimer disease, among others.
Children With Autism Found to Have Higher Risk for Obesity
Autism spectrum disorders (ASDs) appear to increase the risk for childhood obesity.
Prevalence of Pediatric Developmental Disability Has Increased Over Last Decade
Between 2009 and 2017, the prevalence of developmental disability increased among US children aged 3 to 17 years.
Anemia in Early Pregnancy May Harm Child Neurodevelopment
Anemia diagnosed during the first 30 weeks of pregnancy is associated with an increased risk for autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability.
The Influence of Genetics on Variability of Autism Occurrence
Variation in autism spectrum disorder occurrence may be due to genetic influences, rather than maternal or environmental effects.
Developmental Deceleration Linked to Elevated Risk for Autism Spectrum Disorder
Existing developmental screening tools could be used to detect autism spectrum disorder more reliably and at younger ages.
FDA Grants Fast Track Status to Microbiota Transfer Therapy for Autism
The FDA has granted Fast Track status to the microbiota transfer therapy, Full-Spectrum Microbiota (FSM), for the treatment of children with autism spectrum disorder.
Next post in Pediatric Neurology
